Catherine Wood is the founder of ARK Investment Management, a hedge fund based in New York. Over the years, she has made wise investments in technology-related growth stocks. Her broad portfolio has something for everyone. Teladoc Health, Inc., a virtual healthcare company that is a disruptor in the healthcare industry, is one of ARK Investment’s smart bets. The stock has risen more than 139 percent in the last year as the pandemic has bolstered the company’s main business strategy. Exact Sciences Corporation has been rapidly growing to establish itself as the world’s leading cancer screening company. Wood is also optimistic about CRISPR Therapeutics AG, a Swiss biotech company. The biotech firm accounts for 2% of ARK’s investment portfolio. The ARK Innovation ETF returned 152 percent to investors in 2020.
Here is Insider Monkey’s list of the 10 best biotech stocks to buy according to Cathie Wood. Novartis AG is a biotechnology and pharmaceutical company based in Switzerland that was founded in 1996. According to Cathie Wood, it ranks tenth on our list of the top ten biotech stocks to purchase. In the last year, Novartis stock has returned more than 3.4 percent to investors. Iovance Biotherapeutics, Inc. is a biopharmaceutical company based in California that was created in 2007. According to Cathie Wood, it is ranked ninth on the list of the top ten biotech stocks to purchase. Iovance focuses on developing medicines that increase the immune system’s ability to combat cancer cells. Iovance Biotherapeutics, Inc. is a biopharmaceutical company based in California that was created in 2007. According to Cathie Wood, it is ranked ninth on the list of the top ten biotech stocks to purchase. Iovance focuses on developing medicines that increase the immune system’s ability to combat cancer cells. Pacific Biosciences of California, Inc. is a biotech company situated in California that was established in 2004. According to Cathie Wood, it is ranked seventh on the list of the top ten biotech stocks to purchase. In the past year, Pacific stock has returned a phenomenal 619 percent to investors. Twist Bioscience Corporation is a company based in California that sells synthetic DNA. ARK Investment has more than 6 million shares worth $748 million in the company. Twist stock has provided investors with returns of more than 7% in the last week. For more details, click 10 Best Biotech Stocks to Buy According to Cathie Wood.
